Je mi 30+ (žena) — Women's 30+ Panel

Thorough women's health screening at SYNLAB Brno covering blood count, glucose, CRP, lipid profile, liver enzymes, kidney function, minerals, total protein, amylase, and urinalysis with ACR. Tailored for women over 30 as a comprehensive annual health baseline. At 975 CZK (~39 EUR), a fraction of equivalent Austrian pricing.

This panel addresses women's health priorities while maintaining broad metabolic and organ function coverage. The complete blood count with differential is especially relevant for women of reproductive age — iron-deficiency anaemia affects 10-20% of European women aged 15-49 due to menstrual blood loss. The CBC detects it through characteristic findings: low haemoglobin, reduced mean corpuscular volume (microcytosis), and decreased mean corpuscular haemoglobin (hypochromia). Fasting glucose screens for diabetes and assesses future gestational glucose intolerance risk. C-reactive protein provides inflammatory screening applicable to both cardiovascular risk assessment and autoimmune conditions, which disproportionately affect women — autoimmune thyroiditis, rheumatoid arthritis, and systemic lupus erythematosus all have female-to-male prevalence ratios exceeding 3:1. The full lipid panel (total cholesterol, HDL, LDL, triglycerides) is clinically important because cardiovascular disease remains the leading cause of death in women despite being historically underdiagnosed and undertreated compared to men. Oestrogen provides some cardioprotective effect before menopause, but lipid profiles can shift significantly during perimenopause. Liver function assessment (ALT, AST, GGT) screens for hepatocellular damage. Autoimmune hepatitis, with its approximately 4:1 female-to-male ratio, may first present as an incidental transaminase elevation. Kidney function (creatinine, urea) and urinalysis with albumin-creatinine ratio screen for renal disease and urinary tract infections — the latter are far more common in women due to anatomical factors. Calcium and magnesium screening is particularly important for women's bone health. Osteoporosis affects approximately 22% of European women over 50, and maintaining adequate mineral status throughout the pre-menopausal years is a key preventive strategy. Low calcium coupled with vitamin D deficiency accelerates age-related bone density loss. Total protein evaluates nutritional status and hepatic synthetic function. Amylase provides pancreatic screening. For women travelling from Vienna or Bratislava, the Brno price of 975 CZK (~39 EUR) represents roughly one-fifth of what Austrian private laboratories charge for comparable testing. Brno's Moravian capital offers a significantly lower cost of living than Prague, making it an appealing base for combining annual health screening with a cultural city break. Blood draw and serum separation are included. Results within two business days.